Literature DB >> 17713716

Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren's syndrome.

Peter Szodoray1, Katalin Koczok, Antonia Szanto, Ildiko Fanny Horvath, Britt Nakken, Ildiko Molnar, Margit Zeher.   

Abstract

Sjögren's syndrome (SS) is a prototypical systemic autoimmune disease, where autoimmune processes lead to the dysfunction of the exocrine glands. The key feature of the disease is autoimmune exocrinopathy, causing reduced tear secretion and subsequent keratoconjunctivitis sicca (KCS). The aim of this study was to investigate the connection between the presence of autoantibodies to lachrymal gland antigens and the reduced tear production in patients with primary SS. Ninety-nine patients, 90 women and 9 men, were investigated in the study. Twenty healthy young women served as controls. Enzyme-linked immunosorbent assay (ELISA) and Western blotting were applied to detect autoantibodies to antigen fractions prepared from the human lachrymal gland membrane and cytosolic fractions. Autoantibodies of the IgG, IgA and IgM isotypes to the lachrymal membrane and cytosolic fractions were detected in about one third (27%) of the patients with primary SS. IgA antobodies to the membrane and cytosolic fractions occurred most frequently in SS patients. A significant difference was found in the presence of IgA antibodies to the membrane lachrymal fraction between patients and controls given in ELISA indices (1.23 +/- 0.3 vs 1 +/- 0.19, p < 0.001). IgG, IgA, and IgM isotypes of autoantibodies directed to the membrane lachrymal fraction of 200-180, 120-116, 80-70, 58, 50, 48.5, 40 and 28.8 kDa were also identified in patients. Membrane IgG antibody levels showed a positive correlation (R = 0.998; p = 0.045) with the clinical loss of secretory function (Schirmer's test values). Positive correlation was found between membrane IgM and anti-SS-A levels (R = 0.962; p = 0.038) and also between cytosolic IgM antibodies and anti-SS-A levels (R = 0.982; p = 0.018). IgG, IgA and IgM types of autoantibodies may play a role in the development of the impaired lachrymal secretion and therefore may be involved in the pathogenesis of KCS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713716     DOI: 10.1007/s10067-007-0678-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

Review 1.  Pathogenetic factors in Sjögren's syndrome: recent developments.

Authors:  T R Esch
Journal:  Crit Rev Oral Biol Med       Date:  2001

2.  Sjögren's syndrome criteria.

Authors:  R Manthorpe
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 3.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome.

Authors:  R Jonsson; L Klareskog; K Bäckman; A Tarkowski
Journal:  Clin Immunol Immunopathol       Date:  1987-11

6.  Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.

Authors:  D A Jabs; B Lee; J A Whittum-Hudson; R A Prendergast
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

7.  Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjögren's syndrome.

Authors:  M Kuwana; T Okano; Y Ogawa; J Kaburaki; Y Kawakami
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

8.  Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.

Authors:  P Tengnér; A K Halse; H J Haga; R Jonsson; M Wahren-Herlenius
Journal:  Arthritis Rheum       Date:  1998-12

9.  Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.

Authors:  Amelia Ruffatti; Pierantonio Ostuni; Panagiotis Grypiotis; Costantino Botsios; Marta Tonello; Chiara Grava; Maria Favaro; Silvano Todesco
Journal:  J Rheumatol       Date:  2004-03       Impact factor: 4.666

10.  Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome.

Authors:  J Kino-Ohsaki; I Nishimori; M Morita; K Okazaki; Y Yamamoto; S Onishi; M A Hollingsworth
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

View more
  2 in total

1.  Immune Response Targeting Sjögren's Syndrome Antigen Ro52 Suppresses Tear Production in Female Mice.

Authors:  Marta Trzeciak; Harini Bagavant; Joanna Papinska; Umesh S Deshmukh
Journal:  Int J Mol Sci       Date:  2018-09-27       Impact factor: 5.923

2.  Multiple Natural and Experimental Inflammatory Rabbit Lacrimal Gland Phenotypes.

Authors:  Austin K Mircheff; Yanru Wang; Joel E Schechter; Meng Li; Warren Tong; Mayssa Attar; Murty Chengalvala; Joe Harmuth; Jeffery J Prusakiewicz
Journal:  Ocul Surf       Date:  2016-07-15       Impact factor: 5.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.